Clinical Trials Directory

Trials / Completed

CompletedNCT00237640

Effect of Cinnamon on Glucose and Lipid Levels in Non-Insulin Dependent Type 2 Diabetes Mellitus

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
85 (actual)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effects of cinnamon on serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus.

Detailed description

Forty people with non-insulin dependent type 2 diabetes mellitus will be randomized to receive either cinnamon or placebo for three months. The dose of cinnamon will be one gram daily. Fasting serum glucose, triglyceride, total cholesterol, LDL, HDL, and insulin levels will be measured at baseline and at 1, 2, and 3 months. HbA1c levels will be measured at baseline and at 3 months. Patients will be monitored for compliance, adverse effects, and dietary changes.

Conditions

Interventions

TypeNameDescription
DRUGCinnamon or placebo 500 mg capsule twice dailyCinnamon 500 mg capsule twice daily or placebo capsule twice daily

Timeline

Start date
2005-03-01
Primary completion
2007-07-01
Completion
2007-07-01
First posted
2005-10-12
Last updated
2008-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00237640. Inclusion in this directory is not an endorsement.